BridgeMD
New treatment option for Prostate Cancer
Official title 99mTc-MIP-1404 SPECT/CT in Primary Staging of Prostate Cancer
ClinicalTrials.gov ID: NCT06219746
What this study is testing
- What it's testing
- Prostate cancer (PCa) is currently the most common cancer in men in Finland (www.cancerregistry.fi). Although prognosis is very good in majority of men, it is noteworthy that still up to 20% of PCa cases are metastatic at the time of initial diagnosis and yearly 900 men die because of prostate cancer.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, men only
You may be able to join if
- people must be able and willing to give written informed consent and to comply with the requirements of this study protocol
- people must be male, aged 18 years or above at Baseline
- Histopathologically confirmed high risk (Gleason ≥4+4, PSA ≥20 and/ or cT≥3a) acinar or ductal adenocarcinoma of prostate
You likely can't join if
- Allergy/sensitivity to study medications or their ingredients
- people unable to provide written informed consent
- people who have any other significant disease or disorder which, in the opinion of the investigator, may either put the subject at risk by...
- people who have a history of drug or alcohol use that, in the opinion of the investigator, would interfere with adherence to study requirements.
- people who have androgen deprivation therapy initiated before enrolment
- people who have claustrophobia
The study team makes the final eligibility decision.
Where it's taking place
- Turku, Southwest Finland, Finland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Turku, Southwest Finland, Finland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.